🔎 Trials Near Me

Home › Steatotic Liver Disease › Indiana › Indianapolis

Steatotic Liver Disease clinical trials in Indianapolis, IN

6 studies for Steatotic Liver Disease are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RecruitingPhase 3
  • Indiana University Health University Hospital, Indianapolis
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RecruitingPhase 3
  • Akero Clinical Study Site, Indianapolis
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

RecruitingPhase 2
  • GSK Investigational Site, Indianapolis
Ages 18 to 70 · All sexes · Updated Aug 3, 2026 · NCT06613698

Fibrosis Lessens After Metabolic Surgery

RecruitingPhase 4Healthy volunteers welcome
  • Indiana University, Indianapolis
Ages 18 to 75 · All sexes · Updated Jul 31, 2026 · NCT06374875

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Recruiting
  • Indiana University Health, Indianapolis
Ages 18 to 75 · All sexes · Updated May 19, 2026 · NCT04054310

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.